Maryland-based BodeVet, a developer of transfusion treatment options for the veterinary industry, has added three new locations for the clinical trial of StablePlate RX, a product used to treat acute uncontrolled hemorrhage in bleeding canine patients. Marketed as the world’s first injectable, free-dried platelet-derived product, StablePlate RX is now being tested at Ethos Veterinary Health-owned Veterinary Specialty Hospital of San Diego and Wheat Ridge Animal Hospital in Denver, as well as the Randall B. Terry Jr. Companion Animal Veterinary Medical Center at North Carolina State University in Raleigh. “We now have 40 dogs enrolled in 11 clinical sites across the country to evaluate StablePlate RX Canine for control of life threatening hemorrhage in thrombocytopenic patients,” said Anne Hale, DVM, CTO at BodeVet. BodeVet’s existing trial sites include: Blue Pearl Specialty & Emergency Veterinary Hospital in Clearwater, Fla. Blue Pearl Specialty & Emergency Veterinary Hospital in Tampa, Fla. Blue Pearl Specialty & Emergency Veterinary Hospital in Queens, N.Y. Blue Pearl Specialty & Emergency Veterinary Hospital in Paramus, N.J. Blue Pearl Specialty & Emergency Veterinary Hospital in Spring, Texas Cornell University College of Veterinary Medicine Companion Animal Hospital in Ithaca, N.Y. University of Georgia College of Veterinary Medicine Veterinary Teaching Hospital in Athens, Ga. Iowa State University College of Veterinary Medicine Hixson-Lied Small Animal Hospital in Ames, Iowa. The study’s findings are expected to be reported later this year.
